Assort Health
NativePrivateUpdated November 3, 2026AI voice-agent platform for healthcare scheduling/calls
- Website
- www.assorthealth.com
- CEO
- Jeffery Liu and Jon Wang (co-CEOs)
- Founded
- 2023
- HQ
- San Francisco, United States
- Total Funding
- $222M
- Employees
- 201-500
Products & Offerings
Assort AI Voice Agent
Specialty-trained voice agent that answers patient calls 24/7 and handles scheduling, intake, triage, refills and FAQs using each practice's own protocols.
Assort Patient Access & Engagement Platform (Assort OS)
Platform that connects scheduling, intake, outbound outreach, referrals and billing across the patient journey, with EHR integrations and analytics.
Assort Referrals Agent
AI agent that processes inbound referrals, confirms eligibility, matches patients to the right providers and books them; the company says it automates about 90% of referrals end-to-end.
Assort Dermatology Agents
Voice agents tuned for dermatology workflows; the company reports more appointment volume and higher front-desk capacity.
Assort Outbound Outreach
Proactive AI calls and texts for reminders, pre-visit check-ins, recalls and post-visit follow-up to reduce no-shows.
Executive Summary
What they do
- AI voice agents that answer and place patient calls for practices and health systems
- Automates scheduling, intake, triage, referrals, reminders and billing calls across 23+ specialties
- Agents complete scheduling actions directly in EHRs such as NextGen Enterprise and Nextech
Why it matters
- Phone calls drive most bookings, and long holds and abandoned calls lose patients
- Customer case studies claim hold times down 89% and call abandonment down 81%
- $222M+ raised, including a $120M Series C at a $1.2B valuation
Best fit
- Multi-provider specialty practices with complex scheduling rules and heavy call volume
- Ophthalmology, dermatology and orthopedic groups on Nextech or NextGen EHRs
- Health systems wanting to cut call-center staffing and automate referral intake
Watch-outs
- No public pricing; one buyer site reports a $75K annual minimum
- Large health-system rollouts only began in earnest after mid-2026 funding
- Clinical triage and PHI handling need careful safety, escalation and HIPAA review
Latest News
Yahoo Finance · 1 day ago
PositiveFierce Healthcare · 25 days ago
PositiveTipRanks · 25 days ago
PositivePR Newswire · 25 days ago
PositiveThe Business Journals · 1 month ago
PositiveUnlock Full Intelligence
Pro members get the complete briefing
- Complete analyst verdict
- Risk assessment
- All 6 Bluescore dimension scores
- Traction signals
- Bluescore history & momentum tracking
- Unlimited company access
Assort Health is one of the best-funded and most widely deployed voice-AI vendors for patient access. It has a KLAS report on customer outcomes, deep specialty-specific workflows, and new EHR partnerships with Nextech and NextGen, so specialty practices and health systems buying phone automation should shortlist it. Before committing, confirm EHR write-back depth for your system, rules for escalating to humans in triage, and pricing minimums, and check health-system references because that segment is newer for the company.
Signal Provenance
Latest observation date and source for each signal category
| Signal Category | Last Updated | Source |
|---|---|---|
Funding Signals Last funding round, Funding stage | Oct 31, 2026 | Montclare research agents |
Hiring Velocity Headcount, Headcount growth | Nov 3, 2026 | Montclare research agents |
Technical Output Research papers, GitHub activity | Nov 3, 2026 | Montclare research agents |
News Sentiment News mentions, News sentiment | Nov 3, 2026 | Montclare research agents |
Partnership Signals Enterprise partnerships, Distribution partners | Nov 3, 2026 | Montclare research agents |
Revenue Indicators ARR estimate, Revenue growth | Nov 3, 2026 | Montclare research agents |
Leadership Signals CEO tenure, Founder-led | Nov 3, 2026 | Montclare research agents |
Competitive Position Category rank, Market share | Never | Montclare research agents |
Why this Bluescore?
6 dimensions, each scored 0–10 against all — companies. Each adds its weight × score to the Bluescore — see methodology